Eldrin Foster Lewis, MD, MPH

Listen to this article


Eldrin F. Lewis, MD, MPH — Director of the Cardiovascular Clerkship Program at Brigham and Women’s Hospital (BWH)

Dr. Lewis is in his 16th year as a faculty member in the cardiovascular division at Brigham and Women’s Hospital and is an Associate Professor of Medicine at Harvard Medical School. He received his B.S. Degree in Pre-medicine at Pennsylvania State University, his M.D. at University of Pennsylvania School of Medicine where he won the Joel Gordon Miller Award for community service and leadership, and Masters in Public Health degree from Harvard School of Public Health.  He completed training in internal medicine and cardiology at Brigham and Women’s Hospital in Boston followed by an additional year of subspecialty training in heart failure and transplantation.

Dr. Lewis was one of the first recipients of the Minority Faculty Development Award, which is a 7-year award given to promising young physicians with research potential. He is involved with several large, international clinical trials and has approximately 140 publications during his career. He also received a grant from the Robert Wood Johnson Foundation to study the role of quality of life assessment in clinical decision making in patients with heart failure and several grants from the National Institutes of Health.

Dr. Lewis is Vice Chair of the Clinical Cardiology Council of American Heart Association Heart Failure and Director of the Cardiology clerkship for Harvard Medical School students who rotate at Brigham and Women’s Hospital. He is also on the National AHA Research Committee, Chair of Association of Black Cardiologist Research Committee, President of the Boston AHA Board of Directors, and a member of the AHA Founders Affiliate Board of Directors.  Dr. Lewis is an international expert in the area of quality of life and heart failure and serves on scientific committees to review grants for the American Heart Association and the FDA Task Force for the Standardization of Definitions for Endpoint Events in Cardiovascular Trials. He is also on several editorial boards for cardiovascular journals and just completed his role as an Associate Editor for Circulation-Heart Failure.